Home

Venrock Healthcare Capital Partners III, 10% Owner: KalVista Pharmaceuticals KALV Buy · Filed 24/01/24

Trade details

Type
Insider buy
Amount
$847,702.3
Shares · price
67,546 sh · $12.55 a share
Held after
4,527,197 sh
Trade date
24/01/22
Filed
24/01/24
Days to filing
2 days

First buy since 2023

Insiders buying this week
7 insiders
Holding change
+1.5%

KalVista Pharmaceuticals trades, last 26 weeks

What else happened in KalVista Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/12/23~24/02/21

Venrock Healthcare Capital Partners III's recent trades